RadNet, Inc. (RDNT) Major Shareholder Sandy Nyholm Kaminsky Sells 1,100,000 Shares
RadNet, Inc. (NASDAQ:RDNT) major shareholder Sandy Nyholm Kaminsky sold 1,100,000 shares of the business’s stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $10.95, for a total transaction of $12,045,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.
RadNet, Inc. (NASDAQ:RDNT) traded down 1.28% during mid-day trading on Tuesday, reaching $11.60. The company had a trading volume of 366,053 shares. The firm’s 50-day moving average is $10.49 and its 200-day moving average is $7.88. The firm has a market capitalization of $548.29 million, a P/E ratio of 61.05 and a beta of 0.95. RadNet, Inc. has a one year low of $5.25 and a one year high of $11.90.
RadNet (NASDAQ:RDNT) last released its quarterly earnings data on Tuesday, August 8th. The medical research company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.07. RadNet had a net margin of 1.04% and a return on equity of 19.98%. The company had revenue of $230.00 million during the quarter, compared to analyst estimates of $230.32 million. During the same quarter in the previous year, the business posted $0.09 EPS. RadNet’s revenue for the quarter was up 5.2% compared to the same quarter last year. On average, equities research analysts anticipate that RadNet, Inc. will post $0.30 earnings per share for the current fiscal year.
Several brokerages recently commented on RDNT. TheStreet raised RadNet from a “c” rating to a “b-” rating in a research note on Thursday, August 24th. BidaskClub raised RadNet from a “buy” rating to a “strong-buy” rating in a research note on Thursday, August 24th. Finally, Jefferies Group LLC raised RadNet from a “hold” rating to a “buy” rating and boosted their target price for the company from $7.00 to $12.00 in a research note on Tuesday, August 22nd. Two analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $9.63.
A number of large investors have recently bought and sold shares of RDNT. Susquehanna International Group LLP increased its stake in RadNet by 336.0% in the second quarter. Susquehanna International Group LLP now owns 33,043 shares of the medical research company’s stock valued at $256,000 after purchasing an additional 47,043 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of RadNet by 6.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 33,305 shares of the medical research company’s stock worth $258,000 after purchasing an additional 1,997 shares in the last quarter. State Street Corp boosted its position in shares of RadNet by 9.2% during the 2nd quarter. State Street Corp now owns 585,218 shares of the medical research company’s stock worth $4,538,000 after purchasing an additional 49,186 shares in the last quarter. Cornerstone Capital Management Holdings LLC. boosted its position in shares of RadNet by 104.4% during the 2nd quarter. Cornerstone Capital Management Holdings LLC. now owns 102,000 shares of the medical research company’s stock worth $789,000 after purchasing an additional 52,099 shares in the last quarter. Finally, Parallax Volatility Advisers L.P. boosted its position in shares of RadNet by 122.0% during the 2nd quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock worth $164,000 after purchasing an additional 117,148 shares in the last quarter. Institutional investors and hedge funds own 48.81% of the company’s stock.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Stock Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related stocks with our FREE daily email newsletter.